Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Proposed 'Aging Onion' framework for evaluating candidate anti-aging interventions

The authors propose the 'Aging Onion', a layered two-axis framework meant to link evolutionary accounts of aging with intervention assessment, and use caloric restriction and rapamycin in nutrient sensing as an initial test domain. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The authors propose the 'Aging Onion', a layered two-axis framework intended to integrate evolutionary accounts of aging and support intervention assessment. [1]

  2. Caloric restriction is described as a conserved reference intervention and rapamycin as a narrower pharmacological comparator acting mainly through TOR-centred signalling. [1]

  3. The authors outline future directions to test whether the framework can be operationalised and whether its layered logic generalises beyond nutrient sensing. [1]

The source at a glance

Study type / format
Conceptual framework proposal (abstract)
Population / context
Not applicable; the source is a conceptual proposal about aging biology and intervention assessment.
Summary based on
Study abstract
Original publication
June 15, 2026

Proposed framework linking evolution and intervention assessment

The authors state that geroscience lacks a unifying framework that both integrates evolutionary accounts of aging and is directly useful for assessing interventions. They therefore propose the 'Aging Onion', described as a layered, two-axis framework intended to help interpret the diversity of phenotypes associated with aging. It is informed by the mechanistic emphases of the Disposable Soma and Hyperfunction traditions. The two broad biological axes are persistent activity of growth and developmental programmes and insufficient somatic maintenance; through these the authors attempt to interpret age-related degeneration and intervention responses. This is a proposal, not a validated assessment tool.

Supporting source [1]

Caloric restriction and rapamycin as nutrient-sensing benchmarks

To examine the framework's utility, the authors focus on nutrient sensing as an initial benchmark domain. Within this space they describe caloric restriction as a conserved reference intervention and rapamycin as a narrower pharmacological comparator acting primarily through TOR-centred signalling. They ask whether the proposed axes can help ground the mechanistic divergence between these interventions in aging-relevant biology and thereby interpret their differing efficacies. The abstract does not report new experiments, effect sizes or outcomes for either intervention.

Supporting source [1]

Open questions on generalising the framework beyond nutrient sensing

The authors conclude by outlining future directions: testing whether the framework can be operationalised in broader intervention assessment, and determining whether its layered logic generalises beyond nutrient sensing to other domains of aging biology, including population-genetics approaches. These are stated as open questions rather than demonstrated results. The abstract does not describe validation studies, and it does not establish that the framework improves intervention evaluation.

Supporting source [1]

How to interpret this

This is an abstract only; the full text was not reviewed. The source presents a proposed framework and future directions, not validated results, and reports no experiments, effect sizes or outcomes.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    we propose the 'Aging Onion', a layered,
  2. Finding 2 ↑

    rapamycin provides a narrower pharmacological comparator acting
  3. Finding 3 ↑

    testing whether this framework can be operationalised

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…